Elevated hypoxia-induced IL-6 has been demonstrated to exacerbate myopia by promoting scleral remodeling through the TGF-β1/Smad2/MMP-2 pathway [82], supporting the hypothesis that metabolic inflammation contributes to myopia through a “metabolic-immune-hypoxia” network. This evidence concerns the gene SMAD2 and myopia.